
Chief Complaint
Transplant Diagnosis : Acute myelogenous leukemia ( AML ) ( complex cytogentics refractory to chemotherapy ) . Date of Transplant : 5/6/2010 . Day Post - Transplant : 28 .

Interval History
Diarrhea now improved to soft formed stools with approximately 4 BMs daily , none at night . Appetite > 75 % of normal with no N / V . Admits to mild abdominal pressure prior to BMs but denies pain . Overall doing well . .

Pain Management
Pain Scale : 0 ( 0 none ; 10 worst ) . Patient Controlled Analgesics : Not applicable .


Transplant Status
PROTOCOL / TREATMENT PLAN : 739 / 1932 .
TRANSPLANT TYPE allogeneic unrelated , matched peripheral blood stem cell transplant .
CMV SEROLOGY Donor negative , Recipient negative .
PREPARATIVE REGIMEN : Myeloablative TBI , cyclophosphamide .
GVHD Prophylaxis Methotrexate , Tacrolimus .

Allergies

NKA



Medications

Scheduled Medications
acyclovir 800 mg PO BID
beclomethasone 2 mg PO QID ( beclomethasone in corn oil ( conc 1 mg/mL ) )
budesonide 3 mg PO TID ( budesonide 3 mg oral capsule , extended release )
diphenhydrAMINE 25-5 0 mg PO Q4 Hours
emollients , topical apply to sun exposed areas when outdoors Topical ( sunscreen SPF - 30-50 lotion )
fluconazole 400 mg PO QDay
heparin flush 3 ml for flush IV
magnesium sulfate 64 mEq IV QDay
multivitamin no iron 2 tab Chew QDay
pantoprazole 40 mg PO QDay
sodium chloride 10 ml for flush IV ( Normal Saline Flush )
sulfamethoxazole-trimethoprim 1 tab PO BID on QMTu ( Bactrim DS )
tacrolimus 1.5 mg PO Q12 Hours
ursodiol 600 mg PO BID

PRN Medications
lidocaine / diphenhydramine / Al - Mg hydroxide magic mouthwash 5 ml Swish & Spit Q4 Hours PRN ( as needed for pain )
lorazepam 0.5 - 2mg PO Q4 Hours PRN ( for nausea / vomiting )
miscellaneous item 1 application Topical PRN ( - ) ( Boston Butt Cream )
nepafenac ophthalmic 1 drop ( s ) Left EYE TID PRN ( - ) ( Nevanac )
ondansetron 8 mg PO Q8 Hours PRN ( for nausea / vomiting )
oxycodone 5-1 0 mg PO Q4 Hours PRN ( for pain )
prochlorperazine 10 mg PO Q4 Hours PRN ( for nausea / vomiting )




Review of Systems
CONSTITUTIONAL Symptoms
Denies fever . Denies chills . Denies weakness . Denies sweats .
ENMT
Denies rhinorrhea . Denies mucositis . Denies sinus congestion . Denies sore throat .
CARDIOVASCULAR Symptoms
Denies chest pain . Denies lightheadedness . Denies swelling .
RESPIRATORY Symptoms
Denies cough . Denies shortness of breath .
GASTROINTESTINAL Symptoms soft , loose stools , improving in consistency . , denies abdominal pain , denies nausea , denies vomiting .
MUSCULOSKELETAL Symptoms denies muscle pain .
SKIN Symptoms denies itching , denies rash .
NEUROLOGIC Symptoms denies headaches , denies dizziness .
HEME / LYMPH Symptoms denies bleeding , denies bruising .


Physical Examination
Vital Signs Vital Signs Data .
06/03/2010 09:22 Temperature - C 36.6 degC
Heart Rate 80 bpm
Respiratory Rate 16 br / min
SBP - Noninvasive 110 mmHg
DBP - Noninvasive 78 mmHg
BP Method Manual
BP Extremity RIGHT , Arm , Upper
Weight : Height / Weight / BMI - General .
05/31/2010 10:10 DAILY Weight - kg 82.90 kg CONSTITUTIONAL : well-appearing , no apparent distress .
MENTAL STATUS : alert and oriented x3 , Level of Consciousness : alert , normal mood / affect .
EYES : pupils equal , round , reactive to light , extraocular movements intact , EOMI , normal sclera .
EARS , NOSE , MOUTH , and THROAT : normal mouth and dentition , normal oropharynx .
MUCOSITIS ( WHO Oral Toxicity Scale ) : Grade 0 : No mucositis .
RESPIRATORY / CHEST : normal respiratory effort , lung sounds clear to auscultation bilaterally . .
CARDIOVASCULAR : regular rate and rhythm , no murmur , rub or gallop , no cyanosis or edema .
GASTROINTESTINAL : normal bowel sounds , abdomen non-tender , abdomen non-distended , no hepatomegaly , no splenomegaly .
MUSCULOSKELETAL : normal gait / stance .
SKIN : Lesions / Rash : BSA 3 % , rash , erythema ( mild maculopapular rash at base of throat / upper chest . ) , right hickman line intact . no erythema , tenderness , inflammation . .
NEUROLOGIC : cranial nerves II - XII intact .


Laboratory Studies

Laboratory Studies ( Most recent results in 24 hour range . )

RESULTS FROM TODAY
RESULTS FROM YESTERDAY

06/03/10 07:06
06/02/10 09:57


| - ICa - - -
| - ICa - - -
142
107
23
| - Ca 9.7

- - -
- - -
- - -
| - Ca - - -
- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < 134
| - Mg 1.6

- - - - - - - - - | - - - - - - - - - - - - - | - - - - - - - - - - - - < - - -
| - Mg 1.4
4.3
23
0.7
| - Phos 4.6

- - -
- - -
- - -
| - Phos - - -


RESULTS FROM TODAY
RESULTS FROM YESTERDAY

06/03/10 07:06
- - -


11.8
| - PT - - -
- - -
| - PT - - -
12.64 ] - - - - - - - - - - - - - - - - - - - - - - [ 166
| - INR - - -
- - - ] - - - - - - - - - - - - - - - - - - - - - - [ - - -
| - INR - - -

35
| - PTT - - -
- - -
| - PTT - - -


( Most recent results for 24 hour range . )
Individual Labs
06/03/2010 07:06
LD ( Total )
212
06/03/2010 07:06
AST ( GOT )
15
06/03/2010 07:06
ALT ( GPT )
14
06/03/2010 07:06
Bilirubin ( Total )
0.5
06/03/2010 07:06
Bilirubin ( Direct )
0.1
06/03/2010 07:06
Protein ( Total )
6.4
06/03/2010 07:06
Albumin
3.4
06/03/2010 07:06
MCV
91
06/03/2010 07:06
Neutrophils
9.23

Antibiotics
No Results Found .

( Most Recent Results for Prior 7 Days . )
Immunosuppressant
06/03/2010 05:00
Tacrolimus Level by LCMSMS
Pending

( Most Recent Results for Prior 14 Days . )
CMV Results
05/31/2010 09:50
CMV Quant ( PCR ) Result
None detected .


Viral / CMV Monitoring
Herpes Group - Serology / Molecular DX .
05/31/2010 09:50 CMV Quant ( PCR ) Interp . M13383
CMV Quant ( PCR ) Specimen Plasma ( Modified )
CMV Quant ( PCR ) Result None detected . copies / mL
CMV Quant ( PCR ) DNA Copies / mL ( Log 10 ) Not Calculated


Radiological Studies
Chest X - Ray : ( 5/23/10 ) Findings / Impression :
Lungs clear . No pneumothorax is present . Right internal jugular
catheter are stable . .


Procedures / Diagnostic Studies
PATHOLOGY : GI biopsies 5/20/10
A ) Duodenum : Edematous duodenal mucosa with rare to occasional apoptotic epithelial cells , possible graft - vs - host disease .
B & C ) Antrum , biopsies : Edematous gastric mucosa with rare to occasional apoptotic epithelial cells , possible graft - vs - host disease
D ) Rectum and sigmoid , biopsies : Edematous colonic mucosa with rare apoptotic epithelial cells , possible graft - vs . - host
disease .


Assessment / Plan
PRIMARY DISEASE : 45 year old man with refractory AML with complex cytogenetics , now day 28 s/p MURD PBSCT with TBI / Cy conditioning .
HEMATOLOGIC : platelet threshold : 10 thousand , Hematocrit threshold : 26 % , Engrafted with mild anemia . Transfusion independent . .
INFECTIOUS DISEASE :
Infection Prophylaxis : Antifungal agent ( s ) : Fluconazole , Bactrim for PCP prophy , Antiviral agent ( s ) : Acyclovir .
Plan :
C . difficile resolved with 2 negative stool samples . Vanco DC 'd on 5 / 31 . Diarrhea significantly improved . There is high likelihood of disrupted colonic flora although management is difficult when considering GVHD as well .
Corona virus positive from 5 / 21 BAL . Chest xray clear . Nasal congestion nearly resolved . .
DRUG MONITORING : Tacrolimus : level pending , Tacrolimus goal 5-15 .
GRAFT-VERSUS-HOST DISEASE :
History of GVHD : GI tract .
Plan :
FK - 506 and post transplant methotrexate prophylaxis .

New onset diarrhea on 5 / 19 , EGD / Flex Sig 5 / 20 . Started empiric beclothemasone and budesonide on 5 / 20 per GI recommendations . Most likely conditioning toxicity , c.diff , and antibiotic effect as he is making improvement but will continue to monitor closely . Final pathology suggestive of residual chemotherapy toxicity versus early GVHD . Will continue B & B for now with possible discontinuation at next visit . .
REGIMEN RELATED TOXICITY : Fatigue , weakness : Improved today . Continue to follow . .
GASTROINTESTINAL :
Loose stools as above . Stable to improving . .
FLUIDS , ELECTROLYTES & NUTRITION : Hypomagnesemia , requiring daily IV repletion . Appetite and food intake signficantly improved . Fluid intake adquate , no IV fluids necessary . Mag level 1.6 today . Increase IV repletion to 40 meq BID . .


Comments
Day 28 BMA obtained today with results pending . Follow for GI symptoms in setting of possible GVHD , c.diff , and treatment effects .


Signature

Judson Hall , PA-C
FHCRC / SCCA
Pager 314-0063

